The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies
Author:
Funder
Key Lab of Wenzhou city-Gynecological Oncology
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference50 articles.
1. Global cancer statistics;A Jemal;CA Cancer J Clin,2011
2. ROMA, an algorithm for ovarian cancer;AM Chudecka-Glaz;Clin Chim Acta,2015
3. Progress and challenges in screening for early detection of ovarian cancer;IJ Jacobs;Mol Cell Proteomics,2004
4. New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances;J Liu;Clin Cancer Res,2014
5. Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer;B Schluter;J Cancer Res Clin Oncol,2010
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10
2. Synthesis and Biological Assessment of Chalcone and Pyrazoline Derivatives as Novel Inhibitor for ELF3-MED23 Interaction;2024-09-10
3. Synthesis and Biological Assessment of Chalcone and Pyrazoline Derivatives as Novel Inhibitor for ELF3-MED23 Interaction;2024-09-10
4. Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems;International Journal of Nanomedicine;2024-09
5. Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer;International Journal of Molecular Sciences;2024-07-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3